Optibiotix Health Share Discussion Threads

[michaelmouse] 23/5/2018 09:37

Two simple questions that they should have addressed:-

1) How much cash is left?

2) What were revenues from December 2017 - May 2018?

Not difficult to answer, but stony silence from the company.

Tells its own story.

Aimho.

[pglancy] 23/5/2018 09:27

Shrewd you need to chill. Same post 16 mins later.

[shrewdmole] 23/5/2018 09:17

Guys theyve shipped some decent weight this year and I'm sure there will have been license fees paid on some of the deals.

Seed will hit the shelves very quickly then there's Tata and galenicum this year.

Soh obviously isnt concerned and he's the biggest private shareholder.

[pglancy] 23/5/2018 09:14

elrico explained the increased losses and cash burn to 2 events when he was explaining these to MM some time ago. I can't find the post. I remember his saying increased losses were not a cash loss they were a result of ip transfer to sbtx and the increased admin was the cost of the sbtx ipo. Todays cash looks in line with what we already know.

[shazbo] 23/5/2018 09:01

I knew we wouldn’t get figures but I thought he might throw us a bone with a more bullish forward looking statement. Damp squib.

[shrewdmole] 23/5/2018 08:58

Guys theyve shipped some decent weight this year and I'm sure there will have been license fees paid on some of the deals.

Seed will hit the shelves very quickly then there's Tata and galenicum this year.

Soh obviously isnt concerned and he's the biggest private shareholder.

[bobalot] 23/5/2018 08:49

Didn't the company cash in some warrants; if they did the cash position will be better than published since last November.However the business is developing very well imo.

[zebbo] 23/5/2018 08:36

Finances looking strong, looks like some people cannot do the maths. Agree with belgrano2. With zero income we still have 12 months funding

Not even a topic worthy of discussion

[2350220] 23/5/2018 08:32

I've added to my Spreadex December spreadbet this morning.
Unfortunately, their spread is really wide at about 3p.
So I'm quite underwater with all these Spreadbets at the moment.
John

[monkeywench1] 23/5/2018 08:32

I think the Rampers will be very busy for at least 6 months.

[belgrano2] 23/5/2018 08:28

Still 1.25 in the bank, should see this year out even with zero income. Company still being shrewd with expenditure which is a great positive. No unpleasantries that we’ve seen it this runs, about last years revenue.

[tsmith2] 23/5/2018 08:28

Placing ahoy!Rampety ramp

[smarner] 23/5/2018 08:26

A lot has happened since November!

[loungeact] 23/5/2018 08:26

I always go around posting on forums about shares that I would never invest in, it’s what I like to do first thing in the morning, because i’m a big loser in life - Rayrac.

[speccy1] 23/5/2018 08:25

Some have mentioned increased cash burn this morning. Don't forget a significant chunk of that was the cost of spinning off SBTX, which generated a decent increase in assets.

We may have similar costs this year to float Sweetbiotix, but with a similar increase in assets.

My only concern is the cost of returning those assets to shareholders at this stage may delay any free shares or dividends until there's enough income to ensure break-even. Here for long term so willing to wait.

[vanduke] 23/5/2018 08:24

Never held bioprogres.But an OPTI in progress.

[rayrac] 23/5/2018 08:22

Running out of cash, where’s it coming from. Another 6/12months waiting, so cash needed.

Wouldn’t touch.

[1bokke] 23/5/2018 08:19

As you were springs to mind..

[zebbo] 23/5/2018 08:18

Like I have mentioned before. I dont believe we will be around in 12 months
.
Quote
This changes the risk reward ratio leading to an increase in value and the Company and its assets becoming an attractive proposition for corporate partners. This has led to a number of approaches from potential acquirers interested in assets in specific divisions.

Pharma, starting to sniff around, hint was given on the Per's interview the other day

[rayrac] 23/5/2018 08:17

A Bioprogress in progress? Just asking.

[rafboy] 23/5/2018 08:14

I had hoped for a bit more on revenue guidance but there is nothing bad in the results. On the contrary, they show a company in demand, at the cutting edge and with more deals coming on line all the time. We just have to wait a little longer.

[shrewdmole] 23/5/2018 08:12

Well it's given an opportunity to add....

[onedayrodders] 23/5/2018 08:11

like I said yesterday .. plenty of short termers expecting big £££; today

but mm's of course exaggerating the move

Just need to get this week out of the way

would expect buyers later after the sheep have been shawn

[manc10] 23/5/2018 08:11

It's all about 2019 everybody chill out

[primal123] 23/5/2018 08:10

As I posted yesterday from SOH:"Agree, and to overstate the point its six months of agreeing deals. As I have stated (see interims) this is a transition year for research to the start of commercialising products where we are striking the deals with partners and building the foundation for a business based on license deals and royalty payments which are typically paid quarterly of with larger groups 6 monthly. We have openly stated we will give the market forecasts when this process is complete and we can predict revenues with a degree of reliability rather than guess. The success and timing of one or two deals (and when royalties are paid) can change revenues significantly so until this process is complete we will remain cautious and focus on building a solid and sustainable business for or investors rather than hype the market with speculative forecasts."